Baxter International: A Value Opportunity Amidst Restructuring Efforts and Debt Debates

Baxter International's share price has declined by 74% over five years, but its valuation suggests the market may be underpricing the business. A Discounted Cash Flow (DCF) analysis estimates the intrinsic value at around $30.12 per share, indicating a 37.2% discount to its fair value. The stock has inched up 2.3% over the last week and 3.6% over the past month, but its ongoing portfolio reshaping and debates about debt levels and capital allocation keep sentiment cautious.